Search for: "Anda Pharmaceuticals, Inc"
Results 601 - 607
of 607
Sort by Relevance
|
Sort by Date
19 Jan 2007, 5:18 am
The Act permits companies that would like to offer a generic drug that is the bioequivalent of a brand company's drug to make an Abbreviated New Drug Application (ANDA) that includes a statement of the generic's views concerning the patent status of the brand drug. [read post]
14 Dec 2006, 6:47 am
Cir. 2006, 05-1313) Impax had originally filed an ANDA with the FDA seeking approval to market generic riluzole (6-trifluoromethoxy-2-benzothiazolamine) tablets for the treatment of ALS and prompting a suit for a declaratory judgment that Impax did not infringe, induce [...] [read post]
28 Nov 2006, 4:11 pm
Aventis Pharmaceuticals (05-1313). [read post]
21 Nov 2006, 9:58 am
Medtronic AVE, Inc., 339 F.3d 1352, 1363 (Fed. [read post]
27 Oct 2006, 9:43 am
" Life Techs., Inc. v. [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
21 Feb 2006, 10:13 pm
The consolidated defendants (Mylan Laboratories Inc, Mylan Pharmaceuticals, Inc., UDL Laboratories, Inc., Alphapharm Pty. [read post]
